Activation of CXCL13/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of CXCL13/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome
Authors
Keywords
Interstitial cystitis/bladder pain syndrome, Chemokines, Chemokine ligand 13, Chemokine receptor 5, Experimental autoimmune cystitis, Inflammation
Journal
BIOCHEMICAL PHARMACOLOGY
Volume 200, Issue -, Pages 115047
Publisher
Elsevier BV
Online
2022-04-19
DOI
10.1016/j.bcp.2022.115047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Luteolin Improves Cyclophosphamide-Induced Cystitis through TXNIP/NLRP3 and NF-κB Pathways
- (2021) Hengshuai Zhang et al. Evidence-based Complementary and Alternative Medicine
- Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis/Bladder Pain Syndrome with Hunner Lesion
- (2020) Subbroto Kumar Saha et al. Journal of Clinical Medicine
- Suppression of adenosine A2a receptors alleviates bladder overactivity and hyperalgesia in cyclophosphamide-induced cystitis by inhibiting TRPV1
- (2020) Yang Yang et al. BIOCHEMICAL PHARMACOLOGY
- Can the interplay between autophagy and apoptosis be targeted as a novel therapy for Parkinson's disease?
- (2020) Minke Bekker et al. NEUROBIOLOGY OF AGING
- CXCL13/CXCR5 signaling contributes to diabetes-induced tactile allodynia via activating pERK, pSTAT3, pAKT pathways and pro-inflammatory cytokines production in the spinal cord of male mice
- (2019) Sisi Liu et al. BRAIN BEHAVIOR AND IMMUNITY
- Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder
- (2018) Akira Furuta et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis
- (2018) Bo-Ke Liu et al. INFLAMMATION
- Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
- (2018) Luke Grundy et al. Frontiers in Neuroscience
- How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways
- (2018) Krishna Rajarathnam et al. CELLULAR SIGNALLING
- Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis/bladder pain syndrome
- (2016) Dean A. Tripp et al. CUAJ-Canadian Urological Association Journal
- Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice
- (2016) Qian Zhang et al. Journal of Neuroinflammation
- Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder
- (2016) Ji Sung Shim et al. UROLOGY
- The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis
- (2016) Jiang Zhao et al. Scientific Reports
- LPA Promotes T Cell Recruitment through Synthesis of CXCL13
- (2015) Weili Hui et al. MEDIATORS OF INFLAMMATION
- Pathogenetic role of glomerular CXCL13 expression in lupus nephritis
- (2014) K. Worthmann et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Chemokine signaling in development and disease
- (2014) J. Wang et al. DEVELOPMENT
- Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options
- (2014) N.F. Davis et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Urinary Metabolite Profiling Combined with Computational Analysis Predicts Interstitial Cystitis-Associated Candidate Biomarkers
- (2014) He Wen et al. JOURNAL OF PROTEOME RESEARCH
- IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
- (2014) Frency Varghese et al. PLoS One
- CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'
- (2014) Stinne Ravn Greisen et al. ARTHRITIS RESEARCH & THERAPY
- The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome
- (2013) Y.-C. Kuo et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Structural biology of the Bcl-2 family and its mimicry by viral proteins
- (2013) M Kvansakul et al. Cell Death & Disease
- Urinary Chemokines as Noninvasive Predictors of Ulcerative Interstitial Cystitis
- (2012) Pradeep Tyagi et al. JOURNAL OF UROLOGY
- Role of CXCL13 in Asthma
- (2011) Guillermina Juliana Baay-Guzman et al. CHEST
- Prevalence of Symptoms of Bladder Pain Syndrome/Interstitial Cystitis Among Adult Females in the United States
- (2011) Sandra H. Berry et al. JOURNAL OF UROLOGY
- Genome-based expression profiling study of Hunner’s ulcer type interstitial cystitis: an array of 40-gene model
- (2010) Ling-Hong Tseng et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis
- (2009) Marianne Gamper et al. BMC GENOMICS
- The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function
- (2009) Jia Ni et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nicotinic Signaling Ameliorates Acute Bladder Inflammation Induced by Protamine Sulfate or Cyclophosphamide
- (2008) Jonathan S. Starkman et al. JOURNAL OF UROLOGY
- A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation
- (2007) Y. Suzaki et al. EUROPEAN RESPIRATORY JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation